Other Species / Isoforms
  RAB11A (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y8-p
MGTRDDEyDYLFKVV
Upstream
0 78
Treatment
  • FGF1
  • PD173074
RAB11A (human) MGTRDDEyDYLFKVV Y8-p
RAB11A (mouse) MGTRDDEyDYLFKVV Y8-p
RAB11A (rat) MGTRDDEYDYLFKVV Y8
K24-ub
IGDSGVGkSNLLSRF
0 7
RAB11A (human) IGDSGVGkSNLLSRF K24-ub
RAB11A (mouse) IGDSGVGkSNLLSRF K24-ub
RAB11A (rat) IGDSGVGKSNLLSRF K24
S40-p
RNEFNLEsKsTIGVE
0 2
RAB11A (human) RNEFNLEsKsTIGVE S40-p
RAB11A (mouse) RNEFNLEsKsTIGVE S40-p
RAB11A (rat) RNEFNLESKSTIGVE S40
S42-p
EFNLEsKsTIGVEFA
0 10
RAB11A (human) EFNLEsKsTIGVEFA S42-p
RAB11A (mouse) EFNLEsKsTIGVEFA S42-p
RAB11A (rat) EFNLESKSTIGVEFA S42
Y73-p
DTAGQERyRAITsAY
0 115
RAB11A (human) DTAGQERyRAITsAY Y73-p
RAB11A (mouse) DTAGQERYRAITsAY Y73
RAB11A (rat) DTAGQERYRAITsAY Y73
S78-p
ERyRAITsAYYRGAV
0 17
RAB11A (human) ERyRAITsAYYRGAV S78-p
RAB11A (mouse) ERYRAITsAYYRGAV S78-p
RAB11A (rat) ERYRAITsAYYRGAV S78-p
Y91-p
AVGALLVyDIAKHLt
0 1
RAB11A (human) AVGALLVyDIAKHLt Y91-p
RAB11A (mouse) AVGALLVYDIAKHLT Y91
RAB11A (rat) AVGALLVYDIAKHLT Y91
T98-p
yDIAKHLtyENVERW
0 1
RAB11A (human) yDIAKHLtyENVERW T98-p
RAB11A (mouse) YDIAKHLTYENVERW T98
RAB11A (rat) YDIAKHLTYENVERW T98
Y99-p
DIAKHLtyENVERWL
0 1
RAB11A (human) DIAKHLtyENVERWL Y99-p
RAB11A (mouse) DIAKHLTYENVERWL Y99
RAB11A (rat) DIAKHLTYENVERWL Y99
S115-p
ELRDHADsNIVIMLV
0 3
RAB11A (human) ELRDHADsNIVIMLV S115-p
RAB11A (mouse) ELRDHADsNIVIMLV S115-p
RAB11A (rat) ELRDHADSNIVIMLV S115
K145-ub
EARAFAEkNGLSFIE
Downstream
1 6
Effects on Modified Protein
  • enzymatic activity, induced
  • receptor recycling, induced
RAB11A (human) EARAFAEkNGLSFIE K145-ub
RAB11A (mouse) EARAFAEkNGLSFIE K145-ub
RAB11A (rat) EARAFAEKNGLSFIE K145
T167
NVEAAFQTILTEIYR
0 1
RAB11A (human) NVEAAFQTILTEIYR T167
RAB11A (mouse) NVEAAFQtILtEIyR T167-p
RAB11A (rat) NVEAAFQTILTEIYR T167
T170
AAFQTILTEIYRIVs
0 1
RAB11A (human) AAFQTILTEIYRIVs T170
RAB11A (mouse) AAFQtILtEIyRIVS T170-p
RAB11A (rat) AAFQTILTEIYRIVS T170
Y173
QTILTEIYRIVsQkQ
0 1
RAB11A (human) QTILTEIYRIVsQkQ Y173
RAB11A (mouse) QtILtEIyRIVSQkQ Y173-p
RAB11A (rat) QTILTEIYRIVSQKQ Y173
S177-p
TEIYRIVsQkQMSDR
Upstream
Downstream
2 1
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • endocytosis, inhibited
Kinase, in vitro:
  • PKCB iso2 (human)
  • PKCE (human)
Treatment
  • endothelin
RAB11A (human) TEIYRIVsQkQMSDR S177-p
RAB11A (mouse) tEIyRIVSQkQMSDR S177
RAB11A (rat) TEIYRIVSQKQMSDR S177
K179-ub
IYRIVsQkQMSDRRE
0 8
RAB11A (human) IYRIVsQkQMSDRRE K179-ub
RAB11A (mouse) IyRIVSQkQMSDRRE K179-ub
RAB11A (rat) IYRIVSQKQMSDRRE K179
S190-p
DRRENDMsPSNNVVP
0 3
RAB11A (human) DRRENDMsPSNNVVP S190-p
RAB11A (mouse) DRRENDMsPSNNVVP S190-p
RAB11A (rat) DRRENDMSPSNNVVP S190
K207-ub
VPPTTENkPKVQCCQ
0 1
RAB11A (human) VPPTTENkPKVQCCQ K207-ub
RAB11A (mouse) VPPTTENKPKVQCCQ K207
RAB11A (rat) VPPTTENKPKVQCCQ K207